Mestronaq
Category
Mestronaq Brand names, Mestronaq Analogs
Mestronaq Brand Names Mixture
- Cimicifuga Plex (Caulophyllum Thalictroides + Cimicifuga Racemosa + Copper + Cotton Plant + Estrone + Histamine Dihydrochloride + Hypothalamus + Magnesium Phosphate Dibasic + Pituitary Whole + Platinum + Sepia Officinalis L + Thyroid)
- Holis 98 (Dioscorea Vilosa + Estrone + Salvia + Saw Palmetto)
Mestronaq Chemical_Formula
C18H22O2
Mestronaq RX_link
No information avaliable
Mestronaq fda sheet
Mestronaq msds (material safety sheet)
Mestronaq Synthesis Reference
G. Anner, K. Miescher, and Helv. Chem. Acta. 31, 2173(1948)
Mestronaq Molecular Weight
270.366 g/mol
Mestronaq Melting Point
254.5-256 oC
Mestronaq H2O Solubility
3 g/100mL
Mestronaq State
Solid
Mestronaq LogP
4.067
Mestronaq Dosage Forms
Vaginal cream; Vaginal suppository; Patch; Skin gel; Tablet; IM injectable suspension
Mestronaq Indication
For management of Menopausal and postmenopausal disorders
Mestronaq Pharmacology
Estrone, a synthetically prepared or naturally occurring steroidal estrogen obtained from pregnant equine urine, is the primary circulating estrogen after menopause. Estrone is naturally derived from the peripheral conversion of androstenedione by an aromatase enzyme found in adipose tissues and is converted to estradiol in peripheral tissues. Estropipate is piperazine-stabilized estrone sulfate. Estrone, and estropipate are used to treat abnormalities related to gonadotropin hormone dysfunction, vasomotor symptoms, atrophic vaginitis, and vulvar atrophy associated with menopause, and for the prevention of osteoporosis due to estrogen deficiency.
Mestronaq Absorption
43%
Mestronaq side effects and Toxicity
Symptoms of overdose include nausea and vomiting. Withdrawal bleeding may occur in females.
Mestronaq Patient Information
Mestronaq Organisms Affected
Humans and other mammals
